Patient characteristic (N = 183) | N (%) or median (range) |
---|---|
Age | 66 years (37–91 years) |
Gender: | |
Male | 115 (62.8 %) |
Female | 68 (37.2 %) |
Disease status: | |
Newly diagnosed | 136 (74.3 %) |
Relapsed | 47 (25.7 %) |
Chain Isotype: | |
IgG | 93 (50.8 %) |
IgA | 22 (12.0 %) |
Light chain | 29 (15.9 %) |
Other | 9 (4.9 %) |
Missing | 30 (16.4 %) |
Time from diagnosis to presentation | |
All patients | 195 days (11–5090 days) |
New diagnosis of MM | 109 days (11–1902 days) |
Relapse of MM | 1929 days (171–5090 days) |
Previous autologous stem cell transplant | 65 (35.5 %) |
Bisphosphonate therapy | |
Intravenous | 113 (61.8 %) |
Oral | 4 (2.2 %) |
None recorded | 66 (36.0 %) |
Acute vertebral compression fractures: | |
Number of fractures per patient | 3 fractures (0–15 fractures) |
Thoracic region (number of patients) | 149 (81.4 %) |
Lumbar region (number of patients) | 111 (60.7 %) |
Thoracic and lumbar fractures (number of patients) | 85 (46.5 %) |
No non-healed fractures | 7 (3.8 %) |